Market-Moving News for September 12th
Market-Moving News for September 12th
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.
CSBR：59％ | Champions Oncology公布的第一季度财务业绩好于预期后，该公司股价走高。此外，Craig-Hallum将该股从持有上调至买入，并维持了6美元的目标股价。
NTGR: 31% | NETGEAR shares are trading higher after the company disclosed a settlement agreement with TP-Link Systems and raised its Q3 revenue guidance.
NTGR：31％ | NETGEAR的股价走高，此前该公司披露了与TP-Link Systems的和解协议，并提高了第三季度的收入预期。
FULC: -74% | Fulcrum Therapeutics' Phase 3 REACH Trial Of Losmapimod In Facioscapulohumeral Muscular Dystrophy Did Not Achieve Its Primary Endpoint Of Change From Baseline In Relative Surface Area With Losmapimod Compared To Placebo. In Addition, Secondary Endpoints Did Not Achieve Nominal Statistical Significance
FULC：-74% | Fulcrum Therapeutics对洛斯马匹莫德治疗面部肩肱肌萎缩症的3期REACH试验并未实现其主要终点，即与安慰剂相比，洛斯马匹莫德在相对表面积上与基线相比的变化。此外，次要终点未达到名义统计学显著性
